News

2019

company

year

domain

Seres Therapeutics Announces Initiation of SER-287 Phase 2B ECO-RESET Clinical Study for Ulcerative Colitis

Seres Therapeutics 01.03.2019

TARIS Appoints Tony Kingsley as President and Chief Executive Officer

TARIS Biomedical 01.03.2019

The Hard Truth About Innovative Cultures

Flagship Pioneering 01.01.2019

Loading